Jun 02, 2020 / 06:30PM GMT
Michael Jonathan Yee - Jefferies LLC, Research Division - Equity Analyst
Hello, everyone. Welcome to another afternoon session at the 2020 Jefferies Global Healthcare Conference. It's been fantastic so far. And up next with me, I'm really happy to introduce the CEO of Denali Therapeutics, Ryan Watts.
Denali has been on a torrential pace with the pipeline over the last year or 2. And importantly, I think about 2020 as a critically important year for Denali because there's a lot of data reading out this year with all of their programs. So without further ado, Ryan, I'll turn it over to you to give us some update progress and tell us about the milestones coming up.
Ryan J. Watts - Denali Therapeutics Inc. - Co-Founder, President, CEO & Director
Yes. Great. Thanks, Mike. Excellent to be here with all of you remotely at the conference. Looking forward to highlighting some of our science and the progress in terms of the development portfolio. So just a reminder, Denali was founded with one purpose, to defeat degeneration. That goal or purpose extended
Denali Therapeutics Inc at Jefferies Healthcare Conference (Virtual) Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers